Earnings Ahead

VIRX - Viracta Therapeutics

1.43 0.02 1.42

Viracta Therapeutics

Viracta Therapeutics

About

Profile


Headquarters

South San Francisco, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

VIRX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Dosing underway in Viracta Therapeutics' Phase 1b/2 trial of Nana-val in EBV+ solid tumors
  • Viracta Therapeutics stock jumps 9% on Orphan Drug tag in U.S. for Nana-val
  • Viracta Therapeutics EPS misses by $0.09
  • Viracta Therapeutics launches Phase 1b/2 trial of nanatinostat in EBV+ solid tumors
  • Viracta Therapeutics reacquires exclusive rights for oral combination therapy in China
  • Viracta Therapeutics reports Q2 results
  • Viracta Therapeutics gets FDA clearance for early stage carcinoma study
  • Viracta Therapeutics joins Russell 2000, 3000, Microcap indexes
  • Viracta Therapeutics launches nanatinostat combo study in EBV+ lymphoma
  • Viracta Therapeutics files for $200M mixed shelf offering
  • Viracta Therapeutics EPS misses by $5.24
  • Tenet reinstated buy at Goldman Sachs, Adverum downgraded; in today’s healthcare analyst action
  • HCA Healthcare downgraded despite strong Q1 results, LHC Group becomes a new catalyst call; and more in today’s analyst action
  • Xoma is on course for a multi-year high
  • Viracta Therapeutics is ‘an oncology diamond’: Evercore ISI
  • AstraZeneca’s updated data to address integrity issue; Vertex moves to focus list at Citi in today’s analyst action
  • Sunesis Pharma continues momentum after Q4 earnings beat consensus
  • Sunesis rises 1.9% after Viracta sees registration trial in H1 for lymphoma regimen
  • Sunesis Pharma to merge with Viracta Therapeutics in all-stock deal
  • Sunesis Pharmaceuticals EPS beats by $0.06

Earnings History

Date EPS / Forecast Revenue / Forecast
November 10, 2021 -0.4 / -0.31 - / -
August 12, 2021 -0.25 / -0.2367 - / -
May 12, 2021 -5.22 / 0.0233 - / -
March 11, 2021 -0.91 / -0.585 - / -
November 16, 2020 -0.29 / -0.3533 - / -
Date Price Open High Low Vol Change
Apr 26 0.83 0.85
0.85
0.82
36.4K -2.35%
Apr 25 0.85 0.85
0.86
0.82
37.8K 1.19%
Apr 24 0.84 0.87
0.9
0.83
55.1K -1.18%
Apr 23 0.85 0.91
0.91
0.76
83.7K -3.41%
Apr 22 0.88 0.85
0.9
0.84
12.4K 2.33%
 
Apr 19 0.86 0.88
0.91
0.82
52.6K -5.49%
Apr 18 0.91 0.91
0.99
0.85
79.4K -3.19%
Apr 17 0.94 0.74
0.95
0.74
196K 32.39%
Apr 16 0.71 0.77
0.82
0.67
255K -8.97%
Apr 15 0.78 1.03
1.04
0.76
604K -32.17%
Apr 12 1.15 1.3
1.31
1.08
339K -1.71%
Apr 11 1.17 1.15
1.31
1.1
349K 2.63%
Apr 10 1.14 1.08
1.14
1.03
72.0K 7.55%
Apr 9 1.06 1.09
1.11
1.02
76.5K -0.93%
Apr 8 1.07 1.09
1.1
1.03
143K 4.90%
Apr 5 1.02 1.08
1.08
0.99
65.6K -1.92%
Apr 4 1.04 1.09
1.11
1.01
75.7K -4.59%
Apr 3 1.09 1.05
1.09
1.05
72.0K 0%
Apr 2 1.09 1.11
1.12
1.05
111K -1.8%
Apr 1 1.11 1.05
1.15
1.04
248K 8.82%
Mar 28 1.02 1.05
1.08
0.97
60.0K -5.56%
Mar 27 1.08 1.07
1.1
1.05
32.9K 0%
Mar 26 1.08 1.11
1.11
1.05
36.5K 1.89%
Mar 25 1.06 0.96
1.15
0.94
102K 9.28%
Mar 22 0.97 1.04
1.05
0.95
126K -9.35%
Mar 21 1.07 1.14
1.17
1.06
88.9K -5.31%
Mar 20 1.13 1.04
1.13
0.98
93.7K 11.88%
Mar 19 1.01 1.04
1.04
0.98
77.0K 2.02%
Mar 18 0.99 0.97
1.01
0.95
83.4K -1%
Mar 15 1 0.97
1.04
0.94
39.8K 3.09%
Mar 14 0.97 0.94
0.98
0.94
47.6K 2.11%
Mar 13 0.95 1.02
1.05
0.95
76.5K -4.04%
Mar 12 0.99 0.97
1.05
0.93
241K 11.24%
Mar 11 0.89 0.86
0.96
0.86
97.1K 4.71%
Mar 8 0.85 0.83
0.94
0.8
236K 4.94%
Mar 7 0.81 0.91
0.95
0.8
175K -11.96%
Mar 6 0.92 0.93
0.94
0.9
60.2K -2.13%
Mar 5 0.94 0.97
0.98
0.91
104K 0%
Mar 4 0.94 0.95
1
0.91
162K 3.30%
Mar 1 0.91 0.8
0.94
0.8
155K 12.35%
Feb 29 0.81 0.89
0.92
0.76
190K -8.99%
Feb 28 0.89 0.8
0.95
0.79
131K 17.11%
Feb 27 0.76 0.72
0.79
0.7
72.7K 8.57%
Feb 26 0.7 0.7
0.72
0.68
77.7K 0%
Feb 23 0.7 0.73
0.73
0.69
30.4K -1.41%
Feb 22 0.71 0.72
0.74
0.69
24.1K 2.90%
Feb 21 0.69 0.73
0.74
0.68
91.9K -2.82%
Feb 20 0.71 0.68
0.74
0.68
172K 4.41%
Feb 16 0.68 0.65
0.75
0.62
275K 9.68%
Feb 15 0.62 0.62
0.7
0.62
105K 0%
Feb 14 0.62 0.63
0.68
0.6
71.6K -1.59%
Feb 13 0.63 0.67
0.67
0.61
47.1K -3.08%
Feb 12 0.65 0.65
0.69
0.64
107K 4.84%
Feb 9 0.62 0.57
0.66
0.57
175K 10.71%
Feb 8 0.56 0.57
0.58
0.55
30.7K 0%
Feb 7 0.56 0.54
0.62
0.54
100K -9.68%
Feb 6 0.62 0.62
0.62
0.59
45.3K 1.64%
Feb 5 0.61 0.62
0.63
0.56
76.0K -1.61%
Feb 2 0.62 0.62
0.62
0.58
37.0K 3.33%
Feb 1 0.6 0.55
0.62
0.55
48.6K 0%